CA Patent

CA3149182A1 — Therapeutic formulations and uses thereof

Assigned to Bionomics Ltd · Expires 2021-04-01 · 5y expired

What this patent protects

This invention relates to formulations of compound (I) (BNC210), an allosteric modulator of the ?7 -nicotinic receptor with non-sedative anxiolytic effects; specifically, solid dispersions, methods of manufacture thereof, and therapeutic methods and uses in the treatment of disea…

USPTO Abstract

This invention relates to formulations of compound (I) (BNC210), an allosteric modulator of the ?7 -nicotinic receptor with non-sedative anxiolytic effects; specifically, solid dispersions, methods of manufacture thereof, and therapeutic methods and uses in the treatment of diseases of the central nervous system thereof.

Drugs covered by this patent

Patent Metadata

Patent number
CA3149182A1
Jurisdiction
CA
Classification
—
Expires
2021-04-01
Drug substance claim
No
Drug product claim
No
Assignee
Bionomics Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.